• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Psychosis in Parkinson's disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges.帕金森病中的精神病和抗精神病药物初治精神分裂症谱系精神病中的帕金森综合征:临床、分类学和病理生物学挑战。
Acta Pharmacol Sin. 2020 Apr;41(4):464-470. doi: 10.1038/s41401-020-0373-y. Epub 2020 Mar 5.
2
Parkinson's disease psychosis: presentation, diagnosis and management.帕金森病性精神病:表现、诊断与管理
Neurodegener Dis Manag. 2017 Dec;7(6):365-376. doi: 10.2217/nmt-2017-0028. Epub 2017 Nov 21.
3
Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.非典型抗精神病药物治疗帕金森病药物性精神病
Mov Disord. 2000 Mar;15(2):201-11. doi: 10.1002/1531-8257(200003)15:2<201::aid-mds1001>3.0.co;2-d.
4
Pimavanserin for patients with Parkinson's disease psychosis: a randomised, placebo-controlled phase 3 trial.吡贝地尔治疗帕金森病精神病患者的随机、安慰剂对照 3 期试验。
Lancet. 2014 Feb 8;383(9916):533-40. doi: 10.1016/S0140-6736(13)62106-6. Epub 2013 Nov 1.
5
Treatment options for depression and psychosis in Parkinson's disease.帕金森病抑郁和精神病的治疗选择。
J Neurol. 2001 Sep;248 Suppl 3:III12-21. doi: 10.1007/pl00007821.
6
The management of psychosis in movement disorder patients.运动障碍患者的精神病管理
Expert Opin Pharmacother. 2007 May;8(7):935-43. doi: 10.1517/14656566.8.7.935.
7
Use of quetiapine in elderly patients.喹硫平在老年患者中的应用。
J Clin Psychiatry. 2002;63 Suppl 13:21-6.
8
Clinical aspects of comorbid schizophrenia and idiopathic Parkinson's disease.共病精神分裂症和特发性帕金森病的临床特征
Clin Schizophr Relat Psychoses. 2014 Apr;8(1):36-40. doi: 10.3371/CSRP.DEZE.012513.
9
Dopaminergic dysbalance in distinct basal ganglia neurocircuits: implications for the pathophysiology of Parkinson's disease, schizophrenia and attention deficit hyperactivity disorder.不同基底神经节神经回路中的多巴胺能失衡:对帕金森病、精神分裂症和注意力缺陷多动障碍病理生理学的影响。
Neurotox Res. 2006 Dec;10(3-4):167-79. doi: 10.1007/BF03033354.
10
Pimavanserin for Psychosis in Parkinson's Disease-Related Disorders: A Retrospective Chart Review.治疗帕金森病相关疾病所致精神症状的 pimavanserin:回顾性图表分析
Drugs Aging. 2019 Jul;36(7):647-653. doi: 10.1007/s40266-019-00655-y.

引用本文的文献

1
Temporal characteristics of hemodynamic responses during active and passive hand movements in schizophrenia spectrum disorder.精神分裂症谱系障碍中主动和被动手部运动期间血流动力学反应的时间特征。
Schizophrenia (Heidelb). 2025 Aug 6;11(1):109. doi: 10.1038/s41537-025-00654-6.
2
Aberrant preparation of hand movement in schizophrenia spectrum disorder: an fMRI study.精神分裂症谱系障碍中手部运动的异常准备:一项功能磁共振成像研究。
Brain Commun. 2025 Apr 25;7(2):fcaf148. doi: 10.1093/braincomms/fcaf148. eCollection 2025.
3
Gait Disturbance in Patients with Schizophrenia in Relation to Walking Speed, Ankle Joint Range of Motion, Body Composition, and Extrapyramidal Symptoms.精神分裂症患者的步态障碍与步行速度、踝关节活动范围、身体成分及锥体外系症状的关系
Healthcare (Basel). 2025 Mar 10;13(6):604. doi: 10.3390/healthcare13060604.
4
Guideline concordant screening and monitoring of extrapyramidal symptoms in patients prescribed antipsychotic medication: a protocol for a systematic literature review and narrative synthesis.指南一致的抗精神病药物处方患者的锥体外系症状筛查和监测:系统文献回顾和叙述性综合的方案。
BMJ Open. 2024 Sep 12;14(9):e087632. doi: 10.1136/bmjopen-2024-087632.
5
Parkinsonism, Psychomotor Slowing, Negative and Depressive Symptoms in Schizophrenia Spectrum and Mood Disorders: Exploring Their Intricate Nexus Using a Network Analytic Approach.精神分裂症谱系及心境障碍中的帕金森症、精神运动迟缓、阴性和抑郁症状:使用网络分析方法探索它们之间的复杂联系
Schizophr Bull. 2025 Mar 14;51(2):556-570. doi: 10.1093/schbul/sbae055.
6
RNA-seq analysis of gene expression profiles in posttraumatic stress disorder, Parkinson's disease and schizophrenia identifies roles for common and distinct biological pathways.创伤后应激障碍、帕金森病和精神分裂症基因表达谱的RNA测序分析确定了常见和独特生物学途径的作用。
Discov Ment Health. 2022 Mar 3;2(1):6. doi: 10.1007/s44192-022-00009-y.
7
Inflammation, Dopaminergic Brain and Bilirubin.炎症、多巴胺能脑与胆红素。
Int J Mol Sci. 2023 Jul 14;24(14):11478. doi: 10.3390/ijms241411478.
8
Facial and upper-limb movement abnormalities in individuals with psychotic-like experiences: a motion analysis study.具有类精神病体验个体的面和上肢运动异常:一项运动分析研究。
Eur Arch Psychiatry Clin Neurosci. 2023 Sep;273(6):1369-1377. doi: 10.1007/s00406-022-01517-2. Epub 2022 Nov 9.
9
Extrapyramidal symptoms predict cognitive performance after first-episode psychosis.锥体外系症状可预测首次发作精神病后的认知表现。
Schizophrenia (Heidelb). 2022 Aug 4;8(1):64. doi: 10.1038/s41537-022-00270-8.
10
Probable progressive supranuclear palsy in a patient with chronic schizophrenia: A case report.一名慢性精神分裂症患者的疑似进行性核上性麻痹:病例报告。
Exp Ther Med. 2022 Jun 1;24(1):484. doi: 10.3892/etm.2022.11411. eCollection 2022 Jul.

本文引用的文献

1
Systematic epidemiological and clinical comparisons across all 12 DSM-IV psychotic diagnoses in the Cavan-Monaghan First Episode Psychosis Study (CAMFEPS).在卡万-莫纳汉首发精神病研究(CAMFEPS)中,对所有 12 种 DSM-IV 精神病诊断进行系统的流行病学和临床比较。
Psychol Med. 2021 Mar;51(4):607-616. doi: 10.1017/S0033291719003520. Epub 2019 Dec 20.
2
Transdiagnostic Dysfunctions in Brain Modules Across Patients with Schizophrenia, Bipolar Disorder, and Major Depressive Disorder: A Connectome-Based Study.精神分裂症、双相情感障碍和重度抑郁症患者大脑模块中的跨诊断功能障碍:一项基于连接组的研究。
Schizophr Bull. 2020 Apr 10;46(3):699-712. doi: 10.1093/schbul/sbz111.
3
Hallucinations, Delusions and Impulse Control Disorders in Parkinson Disease.幻觉、妄想和帕金森病中的冲动控制障碍。
Clin Geriatr Med. 2020 Feb;36(1):105-118. doi: 10.1016/j.cger.2019.09.004. Epub 2019 Sep 6.
4
Meta-analytic Evidence for the Plurality of Mechanisms in Transdiagnostic Structural MRI Studies of Hallucination Status.幻觉状态跨诊断结构磁共振成像研究中多种机制的荟萃分析证据
EClinicalMedicine. 2019 Feb 21;8:57-71. doi: 10.1016/j.eclinm.2019.01.012. eCollection 2019 Feb.
5
Extrastriatal dopaminergic and serotonergic pathways in Parkinson's disease and in dementia with Lewy bodies: a I-FP-CIT SPECT study.帕金森病和路易体痴呆中纹状体外的多巴胺能和 5-羟色胺能通路:I-FP-CIT SPECT 研究。
Eur J Nucl Med Mol Imaging. 2019 Jul;46(8):1642-1651. doi: 10.1007/s00259-019-04324-5. Epub 2019 May 16.
6
Modifiable risk factors for cognitive impairment in Parkinson's disease: A systematic review and meta-analysis of prospective cohort studies.帕金森病认知障碍的可调节危险因素:前瞻性队列研究的系统评价和荟萃分析。
Mov Disord. 2019 Jun;34(6):876-883. doi: 10.1002/mds.27665. Epub 2019 Mar 14.
7
Overview of the cholinergic contribution to gait, balance and falls in Parkinson's disease.胆碱能系统对帕金森病步态、平衡和跌倒的影响概述。
Parkinsonism Relat Disord. 2019 Jun;63:20-30. doi: 10.1016/j.parkreldis.2019.02.017. Epub 2019 Feb 14.
8
Schizophrenia, Dopamine and the Striatum: From Biology to Symptoms.精神分裂症、多巴胺与纹状体:从生物学到症状。
Trends Neurosci. 2019 Mar;42(3):205-220. doi: 10.1016/j.tins.2018.12.004. Epub 2019 Jan 6.
9
Identification of Common Thalamocortical Dysconnectivity in Four Major Psychiatric Disorders.鉴定四大主要精神障碍中的常见丘脑皮质连接障碍。
Schizophr Bull. 2019 Sep 11;45(5):1143-1151. doi: 10.1093/schbul/sby166.
10
Auditory and visual hallucination prevalence in Parkinson's disease and dementia with Lewy bodies: a systematic review and meta-analysis.帕金森病和路易体痴呆患者的听觉和视觉幻觉患病率:系统评价和荟萃分析。
Psychol Med. 2019 Oct;49(14):2342-2353. doi: 10.1017/S0033291718003161. Epub 2018 Nov 26.

帕金森病中的精神病和抗精神病药物初治精神分裂症谱系精神病中的帕金森综合征:临床、分类学和病理生物学挑战。

Psychosis in Parkinson's disease and parkinsonism in antipsychotic-naive schizophrenia spectrum psychosis: clinical, nosological and pathobiological challenges.

机构信息

School of Pharmacy and Biomolecular Sciences, Royal College of Surgeons in Ireland, Dublin, 2, Ireland.

Jiangsu Key Laboratory of Translational Research & Therapy for Neuro-Psychiatric Disorders and Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou 215123, China.

出版信息

Acta Pharmacol Sin. 2020 Apr;41(4):464-470. doi: 10.1038/s41401-020-0373-y. Epub 2020 Mar 5.

DOI:10.1038/s41401-020-0373-y
PMID:32139896
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7470778/
Abstract

Following the formulation of operational criteria for the diagnosis of psychosis in Parkinson's disease, a neurodegenerative disorder, the past decade has seen increasing interest in such nonmotor psychopathology that appears to be independent of dopaminergic therapy. Similarly, there has been a resurgence of interest in motor aspects of the neurodevelopmental disorder of schizophrenia, including spontaneous parkinsonism that appears to be independent of antipsychotic treatment. This review first addresses the clinical and nosological challenges of these superficially paradoxical insights and then considers pathobiological challenges. It proposes that diverse modes of disturbance to one or more element(s) in a cortical-striatal-thalamocortical neuronal network, whether neurodegenerative or neurodevelopmental, can result in movement disorder, psychosis or both. It then proposes that time- and site-dependent dysfunction in such a neuronal network may be a generic substrate for the emergence of psychosis not only in Parkinson's disease and schizophrenia-spectrum disorders but also in other neuropsychiatric disorders in which psychosis, and sometimes movement disorders, can be encountered; these include substance abuse, cerebrovascular disease, cerebral trauma, cerebral neoplasia, epilepsy, Huntington's disease, frontotemporal dementia, Alzheimer's disease and multiple sclerosis.

摘要

在制定了用于诊断帕金森病(一种神经退行性疾病)中精神病的操作标准后,过去十年中,人们对似乎独立于多巴胺能治疗的这种非运动性精神病理学越来越感兴趣。同样,人们对精神分裂症的神经发育障碍的运动方面重新产生了兴趣,包括似乎独立于抗精神病药物治疗的自发性帕金森病。这篇综述首先讨论了这些表面上矛盾的观点在临床和分类学方面的挑战,然后考虑了病理生物学方面的挑战。它提出,无论是神经退行性还是神经发育性,对皮质-纹状体-丘脑-皮质神经元网络中的一个或多个元素的多种干扰模式都可能导致运动障碍、精神病或两者兼而有之。然后,它提出这种神经元网络的时间和部位依赖性功能障碍可能是精神病出现的一般基础,不仅在帕金森病和精神分裂症谱系障碍中如此,而且在其他可能出现精神病和运动障碍的神经精神障碍中也是如此;这些障碍包括物质滥用、脑血管疾病、脑创伤、脑肿瘤、癫痫、亨廷顿病、额颞叶痴呆、阿尔茨海默病和多发性硬化症。